This group has developed a class of tau ligands specifically utilized for the visualization of diverse tau inclusions within the brains of individuals afflicted with tauopathies, such as Alzheimer’s disease. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.